These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 603190)

  • 1. [Neuroleptic tardive dyskinesias. Completion of the inquiry regarding 1,480 psychiatric hospital patients].
    Bourgeois M; Boueilh P; Peyre C; Gauthier-Bernard F
    Ann Med Psychol (Paris); 1977 Apr; 1(4):660-79. PubMed ID: 603190
    [No Abstract]   [Full Text] [Related]  

  • 2. Tardive dyskinesia: characterization and prevalence in a statewide system.
    Bell RC; Smith RC
    J Clin Psychiatry; 1978 Jan; 39(1):39-47. PubMed ID: 580260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tardive Dyskinesia induced by neuroleptics: a survey of 3140 patients in a psychiatric hospital].
    Bourgeois M
    Encephale; 1977; 3(4):299-320. PubMed ID: 611013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of tardive dyskinesia in psychiatric outpatients.
    Asnis GM; Leopold MA; Duvoisin RC; Schwartz AH
    Am J Psychiatry; 1977 Dec; 134(12):1367-70. PubMed ID: 335900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.
    Davis KL; Berger PA
    Biol Psychiatry; 1978 Feb; 13(1):23-49. PubMed ID: 146524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic dosage, duration, and tardive dyskinesia.
    Allen RE; Stimmel GL
    Dis Nerv Syst; 1977 May; 38(5):385-7. PubMed ID: 852370
    [No Abstract]   [Full Text] [Related]  

  • 7. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables.
    Ezrin-Waters C; Seeman MV; Seeman P
    J Clin Psychiatry; 1981 Jan; 42(1):16-22. PubMed ID: 6109715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of tardive dyskinesia in private psychiatric inpatients.
    Arisco JP; Holden LD
    Tex Med; 1989 Jan; 85(1):25-8. PubMed ID: 2564217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and epidemiologic aspects of tardive dyskinesia.
    Baldessarini RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulnerability to tardive dyskinesia.
    Wolf ME; DeWolfe AS; Ryan JJ; Lips O; Mosnaim AD
    J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Observations of the course of patients with hyperkinesis].
    Schmidt P
    Psychiatr Neurol Med Psychol (Leipz); 1977 Nov; 29(11):689-95. PubMed ID: 605191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of tardive dyskinesia. Part II.
    Jus A; Pineau R; Lachance R; Pelchat G; Jus K; Pires P; Villeneuve R
    Dis Nerv Syst; 1976 May; 37(5):257-61. PubMed ID: 1261344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous and tardive dyskinesias: clinical and laboratory studies.
    Casey DE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):42-7. PubMed ID: 2858480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tardive dyskinesia caused by neuroleptics. Survey of 3,140 psychiatric hospital patients].
    Bourgeois M; Tignol J
    Nouv Presse Med; 1977 Nov; 6(39):3649-50. PubMed ID: 607184
    [No Abstract]   [Full Text] [Related]  

  • 15. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choline chloride in the treatment of Huntington's disease and tardive dyskinesia: a preliminary report.
    Davis KL; Berger PA; Hollister LE; Simonton SC
    Psychopharmacol Bull; 1977 Jul; 13(3):37-8. PubMed ID: 142261
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for tardive dyskinesia according to primary psychiatric diagnosis.
    Wolf ME; DeWolfe AS; Mosnaim AD
    Hillside J Clin Psychiatry; 1987; 9(1):3-11. PubMed ID: 2888712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic approaches to neuroleptic-induced tardive dyskinesias.
    Klawans HL
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():447-57. PubMed ID: 1005908
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G; Cole JO; Schniebolk S; Salomon M
    J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.